- Home
- ABEO vs OCFT Comparison
ABEO vs OCFT Comparison
Compare ABEO & OCFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABEO
- OCFT
- Stock Information
- Founded
- ABEO 1974
- OCFT 2015
- Country
- ABEO United States
- OCFT China
- Employees
- ABEO N/A
- OCFT N/A
- Industry
- ABEO Biotechnology: Pharmaceutical Preparations
- OCFT Computer Software: Programming Data Processing
- Sector
- ABEO Health Care
- OCFT Technology
- Exchange
- ABEO Nasdaq
- OCFT Nasdaq
- Market Cap
- ABEO 289.2M
- OCFT 291.7M
- IPO Year
- ABEO 1980
- OCFT 2019
- Fundamental
- Price
- ABEO $5.49
- OCFT $7.49
- Analyst Decision
- ABEO Strong Buy
- OCFT Hold
- Analyst Count
- ABEO 6
- OCFT 1
- Target Price
- ABEO $18.17
- OCFT $7.98
- AVG Volume (30 Days)
- ABEO 1.0M
- OCFT 20.0K
- Earning Date
- ABEO 11-13-2025
- OCFT 11-13-2025
- Dividend Yield
- ABEO N/A
- OCFT N/A
- EPS Growth
- ABEO N/A
- OCFT N/A
- EPS
- ABEO 0.99
- OCFT N/A
- Revenue
- ABEO $400,000.00
- OCFT $228,020,185.00
- Revenue This Year
- ABEO N/A
- OCFT N/A
- Revenue Next Year
- ABEO $324.71
- OCFT $6.37
- P/E Ratio
- ABEO $5.69
- OCFT N/A
- Revenue Growth
- ABEO N/A
- OCFT N/A
- 52 Week Low
- ABEO $3.93
- OCFT $2.08
- 52 Week High
- ABEO $7.54
- OCFT $7.75
- Technical
- Relative Strength Index (RSI)
- ABEO 44.77
- OCFT 55.47
- Support Level
- ABEO $5.21
- OCFT $7.44
- Resistance Level
- ABEO $5.73
- OCFT $7.55
- Average True Range (ATR)
- ABEO 0.24
- OCFT 0.09
- MACD
- ABEO 0.06
- OCFT -0.01
- Stochastic Oscillator
- ABEO 55.05
- OCFT 21.78
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.
About OCFT OneConnect Financial Technology Co. Ltd.
OneConnect Financial Technology Co Ltd is a technology-as-a-service provider for the financial services industry. It integrates extensive expertise in the industry with market technology to provide technology applications and technology-enabled business services to financial institutions. The integrated solutions and platforms it provides include digital banking solutions, digital insurance solutions, and the Gamma Platform, a technology infrastructure platform for financial institutions. Geographically, the company generates substantially all of its revenue from its business in the People's Republic of China (PRC).